COPD trials in Denmark
31 of 36 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleTHERMotherapy Against Persistent Bacterial LUNG Infections
- Where
- Hellerup
- Age
- 18 years and over
- People
- 150
- Run by
- Chronic Obstructive Pulmonary Disease Trial Network, Denmark
See details and how to joinNCT05351242 - Phase 2Taking peopleA Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Aalborg, Arhus, Copenhagen, Esbjerg, Hvidovre, Roskilde, Vejle
- Age
- 40 years to 75 years
- People
- 606 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00 - Phase 2Not yet taking people in DenmarkThe MAB Trial: A Study of Tozorakimab to Reduce Lung Inflammation and Promote Lung Healing in People with COPD.
- Where
- Copenhagen
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- University Of Leicester
See details and how to join2025-522359-24-00 · EU 2025-522359-24-00 - Phase 3Taking peopleA Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- Where
- Vejle
- Age
- 18 years to 80 years
- People
- 40 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT07555483 · EU 2025-522792-29-00 - Phase 2Taking peopleA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Where
- Aalborg, Aarhus, Esbjerg, Hvidovre, Odense C, Roskilde
- Age
- 40 years and over
- People
- 987 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07082738 - Phase 4Taking peopleA Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Where
- Aalborg, Vejle
- Age
- 40 years to 85 years
- People
- 218 worldwide
- Run by
- Sanofi
See details and how to joinNCT07053423 - Phase 3Taking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Where
- Aalborg, Hvidovre, Næstved, Odense, Vejle
- Age
- 40 years to 80 years
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00 - Phase 3Taking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Where
- Aalborg, Hvidovre, Næstved, Odense C, Vejle
- Age
- 40 years to 80 years
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00 - Phase 2Not yet taking people in DenmarkA Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants with COPD
- Where
- Esbjerg, Odense C, Roskilde, Vejle
- Age
- 18 years and over
- People
- 183 worldwide
- Run by
- Expedition Therapeutics Inc.
See details and how to join2026-525216-34-00 · EU 2026-525216-34-00 - Phase 3Taking peopleDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- Where
- Aalborg, Hvidovre, Roskilde, Vejle
- Age
- 40 years to 80 years
- People
- 981 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06959095 · EU 2024-520418-22-00 - Phase 4Taking peopleStandard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease
- Where
- Aarhus N
- Age
- 40 years and over
- People
- 1,888
- Run by
- Central Denmark Region
See details and how to joinNCT05703919 · EU 2022-502003-30-00 - Phase 3Taking peopleA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Where
- Aalborg, Copenhagen Nv, Esbjerg, Hvidovre, Næstved, Vejle
- Age
- 40 years to 80 years
- People
- 5,250 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00 - No phaseTaking peopleRisk-Based Lung Cancer Detection in COPD Patients
- Where
- Vejle
- Age
- 50 years and over
- People
- 1,000
- Run by
- Vejle Hospital
See details and how to joinNCT07848815 - No phaseTaking peopleAn Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Where
- Copenhagen
- Age
- 40 years to 80 years
- People
- 200 worldwide
- Run by
- Pulmonx Corporation
See details and how to joinNCT06035120 - Phase 3Taking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Where
- Copenhagen Nv
- Age
- 40 years to 80 years
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00 - Phase 2Taking peopleA study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease
- Where
- Aalborg, Aarhus N, Esbjerg, Hvidovre, Odense C, Roskilde
- Age
- 18 years and over
- People
- 307 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-520473-40-00 · EU 2025-520473-40-00 - Phase 3Taking peopleeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- Where
- Aalborg, Hvidovre, Roskilde, Vejle
- Age
- 40 years to 75 years
- People
- 1,196 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00 - No phaseTaking peopleUnilateral vs. Bilateral Lung Volume Reduction Surgery
- Where
- Copenhagen
- Age
- 18 years to 75 years
- People
- 146
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT07731958 - Phase 3Enrolling by invitationLong Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
- Where
- Arhus C, Hellerup
- Age
- 20 years to 72 years
- People
- 290 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT02796937 - Phase 2Taking peoplePsilocybin Therapy for Psychological Distress in Palliative Patients
- Where
- Copenhagen Nv
- Age
- 18 years and over
- People
- 108 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT06782724 · EU 2023-510488-36-01 - No phaseTaking peopleEnhanced COPD Management in Suspected Lung Cancer Patients
- Where
- Vejle
- Age
- 18 years and over
- People
- 280
- Run by
- Ditte Krag-Hansen
See details and how to joinNCT07543601 - No phaseTaking peopleSomatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)
- Where
- Copenhagen
- Age
- 18 years and over
- People
- 2,800
- Run by
- Amager Hospital
See details and how to joinNCT07518446 - No phaseEnrolling by invitationEffect of High-intensity Interval Training on the Lung in Patients With COPD Referred for Lung Volume Reduction Surgery: The PREGENERATE Trial
- Where
- Copenhagen
- People
- 24
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT07343375 - Phase 4Taking peopleComparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
- Where
- Copenhagen, Frederiksberg, Hellerup, Herlev, Hillerød, Holbæk, Hvidovre, Køge, Næstved, Ringsted, Rønne, Roskilde, Slagelse
- Age
- 40 years and over
- People
- 2,000
- Run by
- Copenhagen Respiratory Research
See details and how to joinNCT06892210 - Phase 2Taking peopleEffects of blocking TSLP on airway inflammation and the epithelial immune-response to exacerbation triggers in patients with COPD A randomized double-blind, placebo-controlled trial of Tezepelumab
- Where
- Copenhagen
- Age
- 18 years and over
- People
- 40
- Run by
- Region Hovedstaden
See details and how to joinNCT05507242 · EU 2024-511730-12-00